EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Flavonoids-Enriched Vegetal Extract Prevents the Activation of NFκB Downstream Mechanisms in a Bowel Disease In Vitro Model

Paolo Corbetta iD, Elena Lonati iD, Stefania Pagliari iD, Mario Mauri iD, Emanuela Cazzaniga iD, Laura Botto, Luca Campone iD, Paola Palestini iD, Alessandra Bulbarelli iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25147869 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Paolo Corbetta und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine and Surgery, University of Milano-Bicocca, Via Cadore 48, 20900 Monza, Italy. Hauptthemen laut MEDLINE: Plant Extracts, Flavonoids, NF-kappa B. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Recovery and Resilience Plan (NRRP), Mission 4 Component 2 Investment 1.3 - Call for tender No. 341 of 15 March 2022 of Italian Ministry of University…, National Recovery and Resilience Plan (NRRP), Mission 4. Component 2 Investment 1.3—Call for tender No. 3138, 16 December 2021, rectified by Decree n.341 of 15….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory bowel disease (IBD) incidence has increased in the last decades due to changes in dietary habits. IBDs are characterized by intestinal epithelial barrier disruption, increased inflammatory mediator production and excessive tissue injury. Since the current treatments are not sufficient to achieve and maintain remission, complementary and alternative medicine (CAM) becomes a primary practice as a co-adjuvant for the therapy. Thus, the intake of functional food enriched in vegetal extracts represents a promising nutritional strategy. This study evaluates the anti-inflammatory effects of artichoke, caihua and fenugreek vegetal extract original blend (ACFB) in an in vitro model of gut barrier mimicking the early acute phases of the disease. Caco2 cells cultured on transwell supports were treated with digested ACFB before exposure to pro-inflammatory cytokines. The pre-treatment counteracts the increase in barrier permeability induced by the inflammatory stimulus, as demonstrated by the evaluation of TEER and CLDN-2 parameters. In parallel, ACFB reduces p65NF-κB pro-inflammatory pathway activation that results in the decrement of COX-2 expression as PGE2 and IL-8 secretion. ACFB properties might be due to the synergistic effects of different flavonoids, indicating it as a valid candidate for new formulation in the prevention/mitigation of non-communicable diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Plant ExtractsFlavonoidsNF-kappa BHumansCaco-2 CellsInflammatory Bowel DiseasesInterleukin-8Signal TransductionAnti-Inflammatory AgentsCyclooxygenase 2Intestinal MucosaTrigonellaDinoprostone

Stichwörter der Autor:innen

IBDNF-κB pathwayflavonesfunctional foodin vitro model of the intestinal barrierinflammationpro-inflammatory cytokinesvegetal extract

Substanzen

Plant ExtractsFlavonoidsNF-kappa BInterleukin-8Anti-Inflammatory AgentsCyclooxygenase 2Dinoprostone

Autor:innen und Institutionen

  • School of Medicine and Surgery, University of Milano-Bicocca, Via Cadore 48, 20900 Monza, Italy.
  • Bicocca Center of Science and Technology for Food, University of Milano-Bicocca, Piazza della Scienza 2, 20126 Milano, Italy.
  • ZooPlantLab, Department of Biotechnology and Biosciences, University of Milano-Bicocca, Piazza della Scienza 2, 20126 Milano, Italy.

ORCID-Profile: Paolo Corbetta, Elena Lonati, Stefania Pagliari, Mario Mauri, Emanuela Cazzaniga, Luca Campone, Paola Palestini, Alessandra Bulbarelli

Förderung

  • National Recovery and Resilience Plan (NRRP), Mission 4 Component 2 Investment 1.3 - Call for tender No. 341 of 15 March 2022 of Italian Ministry of University…
  • National Recovery and Resilience Plan (NRRP), Mission 4. Component 2 Investment 1.3—Call for tender No. 3138, 16 December 2021, rectified by Decree n.341 of 15…

Zitieren

APA

Corbetta, P., Lonati, E., Pagliari, S., Mauri, M., Cazzaniga, E., Botto, L., Campone, L., Palestini, P., & Bulbarelli, A. (2024). Flavonoids-Enriched Vegetal Extract Prevents the Activation of NFκB Downstream Mechanisms in a Bowel Disease In Vitro Model. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25147869

Vancouver

Corbetta P, Lonati E, Pagliari S, Mauri M, Cazzaniga E, Botto L, et al. Flavonoids-Enriched Vegetal Extract Prevents the Activation of NFκB Downstream Mechanisms in a Bowel Disease In Vitro Model. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25147869

BibTeX
@article{Corbetta2024,
  author = {Corbetta, Paolo and Lonati, Elena and Pagliari, Stefania and Mauri, Mario and Cazzaniga, Emanuela and Botto, Laura and Campone, Luca and Palestini, Paola and Bulbarelli, Alessandra},
  title = {Flavonoids-Enriched Vegetal Extract Prevents the Activation of NFκB Downstream Mechanisms in a Bowel Disease In Vitro Model},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25147869}
}
Kostenlos starten →